Atomwise Drug Discovery Platform raised $6 million in seed funding Data Collective led the round, with the participation of Khosla Ventures, DFJ, AME Cloud Ventures and OS Fund.
Atomwise technology is a virtual drug discovery platform based on the science of Deep Learning Neural Networks and has previously been used for malaria, multiple sclerosis, C research. Difficult, and Leukemia The system is driven by a virtual brain, modeled on a human visual cortex, which is taught by ‘study’ millions of data points about how drugs have worked in the past. With this vast knowledge, Atomwise’s brain can apply patterns that it perceives to predict the efficacy of hypothetical drugs, and suggest surprising uses of existing drugs, transforming the discovery of medicines.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Atomwise/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
